Fritz Leutmezer

Nueva
Ubicación: Austria, Viena
Clínica:
4.5
Vienna General Hospital
El Dr. Fritz Leutmezer es neurólogo principal en el Hospital General de Viena, uno de los hospitales universitarios más grandes de Europa.
- Presidente de la Sociedad Austriaca de Esclerosis Múltiple (ÖMSG)
- Publicar más de 60 artículos científicos en neurología
- Tratar trastornos neurologicos como la epilepsia y trastornos del movimiento
- Utilizar la acupuntura para ciertos cuadros de dolor relacionados con los nervios
Mostrar más

Nueva

Cita con el médico

Precio a consultar

Bookimed Insights: Principales especialistas en La esclerosis lateral amiotrófica en Austria (2026)

Bookimed ha coordinado 5 solicitudes para el tratamiento de La esclerosis lateral amiotrófica en Austria, colaborando con 1 especialistas de primer nivel. Los médicos en esta tabla se seleccionan por sus credenciales internacionales, experiencia clínica y resultados de pacientes. La clasificación de 2026 se elabora con datos verificados de casos reales y programas actuales de nuestras clínicas asociadas.

Clasificación	Médico	experiencia	Buena opción para	Qué los distingue	Ubicación de la clínica	Consulta
#1	Fritz Leutmezer		Trastornos neurológicos complejos	Ejercer la presidencia de la Sociedad Austriaca de Esclerosis Múltiple y contar con más de 60 artículos de neurología publicados. Médico especialista sénior en un importante hospital universitario.	Vienna General Hospital Austria	Precio a consultar

FAQ

Estas preguntas frecuentes provienen de pacientes reales que buscan atención médica a través de Bookimed. Las respuestas son proporcionadas por coordinadores médicos experimentados y representantes autorizados de las clínicas.

Is stem-cell therapy for ALS available and permitted in Austria?

Stem-cell therapy for ALS is available in Austria primarily through strict clinical trials. While permitted under European Union regulations, it is not a standard medical treatment. Private clinics in Vienna offer autologous protocols using a patient's own bone marrow or fat tissue under specific safety guidelines.

Regulatory oversight: All procedures must comply with European Union Advanced Therapy Medicinal Products (ATMP) standards.
Treatment type: Clinics focus on autologous mesenchymal stem cells to ensure high safety profiles.
Legal access: Access is granted through registered clinical trials or approved individualized treatment protocols.
Neurology expertise: Specialists like Dr. Fritz Leutmezer at Vienna General Hospital (AKH) provide neurological consultations.

Bookimed Expert Insight: Data shows a clear distinction between academic centers and private facilities in Vienna. While large institutions like Vienna General Hospital (AKH) lead research, private hospitals like Wiener Privatklinik offer more personalized diagnostic access. Patients should confirm that any proposed stem-cell protocol is registered with the European Medicines Agency (EMA) to ensure it meets national ethics requirements for ALS care.

Patient Consensus: Patients note that while consultations are easy to book, stem-cell therapy is rarely offered as a standard option outside of research. Many suggest verifying clinical trial status before traveling to Austria for these specific regenerative treatments.

What multidisciplinary ALS care is provided in Austrian centres?

Austrian multidisciplinary ALS care integrates neurology, pulmonology, and nutritional support within centralized university clinics and private facilities. Leading centers like Vienna General Hospital (AKH) coordinate specialized teams. These clinics provide rapid diagnostics, genetic testing, and individualized symptom management through a single-visit approach for complex neurodegenerative care.

Specialized neurology: Dr. Fritz Leutmezer at AKH leads diagnostics and manages medical treatments.
Respiratory management: Pulmonologists coordinate non-invasive ventilation (NIV) to support lung function and comfort.
Nutritional intervention: Gastroenterologists evaluate swallowing safety and manage PEG tube placement for nutrition.
Therapeutic coordination: Teams include physical medicine, speech therapy, and palliative care for holistic support.

Bookimed Expert Insight: Patients can access elite expertise at Wiener Privatklinik, where over 400 physicians include many professors from the Medical University of Vienna. This provides private-sector comfort with the clinical depth of a major academic institution. This combination is ideal for patients seeking rapid diagnostic timelines without sacrificing specialized university-level insights.

Patient Consensus: Patients note that while integrated care for respiratory and nutritional needs is excellent, initiating early physiotherapy often requires persistence. Coordinating quarterly full-team assessments in major cities like Vienna or Innsbruck is recommended to catch swallowing issues early.

How soon can a medical tourist be evaluated and start treatment?

Medical tourists can typically schedule remote neurological evaluations in Austria within 1 to 2 weeks. In-person diagnostic assessments in Vienna generally occur within 48 to 72 hours of arrival. Treatment for ALS often begins 4 to 12 weeks after the initial inquiry.

Consultation speed: Video consults with Austrian specialists are available in 7 to 14 days.
Diagnostic phase: In-hospital evaluations in Vienna usually conclude within 3 days of arrival.
Regulatory wait: Experimental protocols like stem cell therapy may require 8 weeks for approval.
Travel planning: Schengen visa processing for non-European Union residents takes 2 to 4 weeks.

Bookimed Expert Insight: While Vienna General Hospital (AKH) serves over 595,000 patients annually, private facilities like Wiener Privatklinik offer faster access to professors from the Medical University of Vienna. Securing a slot at a private hospital can reduce the administrative wait for rare neurological consultations by several weeks compared to public university tracks.

Patient Consensus: Patients report that preparing medical records in German or English significantly speeds up the process. Many note that while initial evaluations are quick, starting specialized treatments often requires a 2-month window for insurance and ethics clearance.

What are the documented safety risks of intrathecal stem-cell infusion for ALS?

Intrathecal stem-cell infusion for ALS is generally safe and well-tolerated. Most documented risks are mild and temporary. Serious adverse events remain rare. These complications often stem from the lumbar puncture procedure rather than the cells. Most symptoms resolve within days with standard medical care.

Common side effects: Approximately 43% of patients experience temporary headaches after the lumbar puncture.
Physical reactions: Patients may report neck stiffness, back pain, or mild fever.
Neurological risks: Rare cases include transient urinary disorders or temporary increases in muscle spasticity.
Infection control: Sterile techniques minimize risks of meningitis or local site infections.

Bookimed Expert Insight: Clinical data from major Austrian centers like Vienna General Hospital (AKH) shows that safety is linked to institutional volume. Large university hospitals manage over 500,000 patients annually. They follow strict ISO standards that reduce procedural risks. In contrast, small private clinics may lack these rigorous safety benchmarks. Patients should choose facilities with 20+ specialized departments to ensure emergency neurological support is available if needed.

Patient Consensus: Patients emphasize distinguishing between expected post-procedure fevers and acute deterioration. Many note that choosing accredited facilities is vital to avoid spinal infection risks during the infusion.

How long should I plan to stay in Austria for stem-cell therapy and follow-up?

Patients should plan to stay in Austria for 7 to 14 days for ALS stem-cell therapy. This timeframe includes initial neurological evaluations and specialized laboratory cell processing. It also covers the procedure itself and 72 hours of mandatory post-treatment observation before flying.

Neurological evaluation: Initial 1–2 days for baseline motor and respiratory tests.
Cell preparation: Professionals require 3–5 days for harvesting and laboratory processing.
Treatment phase: Procedures typically occur over 1–2 days depending on protocol.
Safety buffer: Doctors mandate 3 days observation to manage ALS-related fatigue.

Bookimed Expert Insight: Major Austrian centers like Vienna General Hospital manage over 500,000 patients annually. Their protocols for complex neurological cases prioritize stability over speed. We see that a 14-day stay significantly improves immediate recovery compared to 5-day trips. Choosing an academic hospital ensures access to multidisciplinary teams if respiratory support is needed.

Patient Consensus: Patients note that ALS-related fatigue can double recovery time compared to other treatments. It is important to arrange caregiver assistance for the flight home and throughout the stay.

Do Austrian clinics provide Edaravone IV for ALS to non-EU patients?

Austrian clinics provide Edaravone IV to non-EU patients through named patient importation schemes. Access is available at specialized centers in Vienna for international cash-pay patients. Physicians legally prescribe these infusions for patients lacking alternative treatments. Administration typically occurs in high-standard private or university hospitals.

Legal access: Physicians use compassionate use programs for non-EU patients.
Infusion cycles: Treatment typically requires a clinic stay of 4–7 days.
Leading centers: Vienna General Hospital (AKH) and Wiener Privatklinik manage ALS protocols.
Medication sourcing: Clinics facilitate legal importation of drugs like Radicava or Radicut.

Bookimed Expert Insight: While Vienna General Hospital (AKH) serves nearly 600,000 patients yearly, its many professors also practice at Wiener Privatklinik. This allows international patients to access the same top-tier university expertise within a more flexible private environment. Private facilities often manage the complex paperwork for importing non-EMA approved drugs faster than large public institutions.

Patient Consensus: Patients note that private clinics in Austria accept non-EU citizens for Edaravone cycles if they pay out-of-pocket. Many emphasize the need to secure a medical visa early due to the long duration of repeating infusion schedules.

Will my health insurance cover ALS treatment in Austria?

Coverage for ALS treatment in Austria depends on residency status and insurance type. Statutory health insurance (ÖGK) covers comprehensive care for residents. EU visitors use the EHIC for standard care. Private international plans often cover medication and therapy. Experimental treatments like stem cell therapy usually require out-of-pocket payment.

Public coverage: Residents receive full diagnostic and specialist care.
Authorized medication: Riluzole is standard and covered by public plans.
Supportive therapies: Physiotherapy and speech therapy are generally included.
EHIC/GHIC usage: Cardholders access public care on par with citizens.

Bookimed Expert Insight: While Vienna General Hospital (AKH) serves over 595,000 patients yearly, residential paperwork takes one to six months. Private clinics like Wiener Privatklinik provide faster access to professors from the Medical University of Vienna. These private facilities often specialize in complex diagnostics for international patients not covered by the public system.

Patient Consensus: Patients note that public insurance covers home adaptations and medication for residents. However, non-residents often pay €200 for specialist visits and must budget extra for home care.

Los mejores médicos del tratamiento de La esclerosis lateral amiotrófica - TOP-1 médicos

Recibe cotizaciones de 3 de los mejores especialistas en en Austria